Risk evaluation and therapeutical implications of pulse pressure in primary arterial hypertension;Risikowertung und therapeutische bedeutung des pulsdruckes bei primärer hypertonie

Deutsche Medizinische Wochenschrift

Volumn 127, Issue 45, 2002, Pages 2396-2399

  Bönner, Gerd ^a  

^a MEDIAN Kliniken GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; ALBUMINURIA; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037048956     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-35356     Document Type: Review

References (23)

1. Cushman WC, Materson BJ, Williams DW et al. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Hypertension 2001; 38: 953-957
2. Domanski MJ, Davis BR, Pfeffer MA et al. Isolated systolic hypertension. Prognostic Information Provided by Pulse Pressure. Hypertension 1999; 34: 375-380
3. Domanski MJ, Mitchell G, Pfeffer MA et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 2002; 287: 2677-2683
4. Domanski MJ, Normann J, Wolz M et al. Cardiovascular risk assessment using pulse pressure in the first national health and nutrition examination survey (NHANES I). Hypertension 2001; 38: 793-797
5. Fagard RH, Pardaens K, Staessen JA et al. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol 2001; 38: 227-231
6. Fang J, Madhavan S, Alderman MH. Pulse pressure: a predictor of cardiovascular mortality among young normotensive subjects. Blood Pressure 2000; 9: 260-266
7. Gerdts E, Papademetriou V, Palmieri V et al. Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol 2002; 89: 399-402
8. Jokiniitty JM, Majahalme SK, Kähönen MA et al. Pulse pressure is the best predictor of future left ventricular mass and change in left ventricular mass: 10 years of follow-up. J Hypertens 2001; 19: 2047-2054
9. Klassen PS, Lowrie EG, Reddan DN et al. Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 2002; 287: 1548-1555
10. Millar JA, Lever AF, Burke V. Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 1999; 17: 1065-1072
11. Ohkubo T, Hozawa A, Imai Y. Prognostic impact of 24-hour mean blood pressure and pulse pressure on stroke. Circulation 2001; 104: E160
12. O'Rourke M, Frohlich ED. Pulse Pressure: Is this a clinically useful risk factor? Hypertension 1999; 34: 372-374
13. Pedrinelli R, Dell'Omo G, Penno G et al. Microalbuminuria and pulse pressure in hypertensive and atherosclerotic men. Hypertension 2000; 35: 48-54
14. Safar ME, Levy BI, Laurent S et al. Hypertension and the arterial system: clinical and therapeutic aspects. J Hypertens 1990; 8: S113-S119(suppl 7
15. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265: 3255-3264
16. Staessen JA, Fagaro R, Thijs L et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350: 757-764
17. Thadhani R, Ecker JL, Kettyle E et al. Pulse pressure and risk of preeclampsia: a prospective study. Obstetrics and Gynecology 2001; 97: 515-520
18. Vaccarino V, Berger AK, Abramson J et al. Pulse pressure and risk of cardiovascular events in the systolic hypertension in the elderly program. Am J Cardiol 2001; 88: 980-986
19. Vasan RS, Larson MG, Leip EP et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001; 345: 1291-1297
20. Vasan RS, Massaro JM, Wilson PWF et al. Antecendent blood pressure and risk of cardiovascular disease. The Framingham Heart Study. Circulation 2002; 105: 48-53
21. Verdecchia P, Schillaci G, Borgioni C et al. Ambulatory pulse pressure. A potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32: 983-988
22. Zanchetti A, Bond MG, Hennig M et al. Risk factors associated with alterations in carotid intima-media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis. J Hypertens 1998; 16: 949-961
23. Deutsche Liga zur Bekämpfung des hohen Blutdruckes, deutsche Hypertoniegesellschaft. Leitlinien für die Prävention, Erkennung, Diagnostik und Therapie der arteriellen Hypertonie. Dtsch Med Wochenschr 2001; 126 (Suppl 4);